InvestorsHub Logo
icon url

Gogo1121

09/12/12 2:45 PM

#81 RE: tank0678 #80

Accentia's management is making every effort to get their vaccine approved in Europe and here in the USA. These things take time and money and that is unfortunately what has created the delay. Share have settled here and are waiting for news that will push shares back to the $2.75 - $3.50 area. Just an opinion...do you own due diligence!